drugset / Trial / NCT02954068

IV Versus IM Administration of Oxytocin for Postpartum Bleeding

NCT02954068

RandomizedParallel-groupDouble-blindPrevention

Summary

This double-blind, randomized controlled trial will evaluate the effect of the route of administration of 10 IU of oxytocin on the average blood loss postpartum. Participants will be randomized to receive 10 IU of oxytocin by IV infusion or 10 IU of oxytocin by injection IM

Timeline

Start
2016-12-01
Primary completion
2017-09-30
Completion
2017-10-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytocin Peptide 10 iu Intravenous

Indications

No indication recorded.